Second Quarter Normalized FFO of $0.30 Reflects 15% and 12%
Increases over Prior Year Quarter and Year to Date Periods
Announced Year to Date Acquisitions of $1.5 Billion Drive
Additional FFO Growth Expectations
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Aug. 4, 2015--
Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE:MPW) today
announced financial and operating results for the second quarter ended
June 30, 2015.
SECOND QUARTER AND RECENT HIGHLIGHTS
-
Achieved second quarter Normalized Funds from Operations (“FFO”) per
diluted share of $0.30, up 15% compared to $0.26 per share reported in
the second quarter of 2014; year to date Normalized FFO of $0.58 per
share represents a 12% increase over the comparable period last year;
-
As previously disclosed, signed definitive agreements to acquire, for
$900 million in cash, Capella Holdings, Inc. (“Capella”), which
includes real estate investments of approximately $600 million and
loans to and investments in operating entities of approximately $300
million; the acquisition is expected to close in the second half of
2015, subject to customary closing conditions including
Hart-Scott-Rodino approval;
-
Initiated long term relationship with AXA Real Estate Investment
Managers (“AXA Real Estate”) to co-invest with AXA-advised accounts
for the acquisition of acute care hospitals in Spain and Italy; the
aggregate commitment for MPT’s 50% interests in the hospitals
approximates €112 million (approximately $122 million);
-
Completed the purchase of 30 MEDIAN facilities for an aggregate
purchase price of approximately €627 million;
-
Completed construction of five Adeptus First Choice ER facilities
(“Adeptus”) and commenced collection of rent at double digit cash
rates; MPT is now receiving rent from 25 Adeptus facilities with 12
more under construction and 11 in pre-construction diligence;
-
Invested $44 million for the acquisition of two facilities in Lubbock,
Texas, including a 60-bed inpatient rehabilitation hospital to be
operated by Ernest Health (“Ernest”) and a 37-bed long term acute care
hospital that is operated by a third party and subleased by Ernest to
that operator;
-
Closed in May on an approximate $20 million development commitment for
an Ernest inpatient rehabilitation hospital in Toledo, Ohio.
Included in the financial tables accompanying this press release is
information about the Company’s assets and liabilities, net income and
reconciliations of net income to FFO and Adjusted Funds from Operations
(“AFFO”), all on a basis comparable to 2014 results.
“Our double digit growth in Normalized FFO continues to demonstrate the
benefits of our hospital real estate investment strategies and further
validates investor expectations for even more growth in the near term,”
said Edward K. Aldag, Jr., Chairman, President and CEO of Medical
Properties Trust. “Last week’s announcement of the $900 million,
immediately accretive Capella transaction is only the most recent
example of our ability to drive growth by partnering with the best
hospital operators. Along with additional investments this year in
current tenants Prime, Ernest, Adeptus and MEDIAN, and a new
relationship with AXA Real Estate in Europe, our total assets are
approaching $6 billion and our diversification is better than ever,”
said Aldag.
PORTFOLIO UPDATE
MPT has previously announced that it has entered into definitive
agreements for the acquisition of a portfolio of seven acute care
hospitals currently owned and operated by Capella, as well as an equity
interest in the operator of the facilities for a combined purchase price
of approximately $900 million. MPT and current Capella management, who
will continue to manage and operate the facilities, have formed a joint
venture that will be the acquiror of Capella and expect to complete
these transactions in the second half of 2015.
As soon as practicable after closing of the merger, MPT will acquire
from and lease back to Capella its interests in five acute care
hospitals for an aggregate purchase price of approximately $390 million
and fund loans secured by first lien mortgages on two hospitals for an
aggregate of approximately $210 million. The blended GAAP yield will
approximate 9.1% of the aggregate $600 million in real estate
investments, which will be offset against the $900 million merger
consideration. The remaining approximately $300 million investment in
the operations of Capella will be in the form of a $290 million
acquisition loan to Capella, which will have a fixed interest rate
equivalent to the initial lease and mortgage loan rate, and a 49%
interest by MPT in the equity of the operator, with management owning
the remaining 51%.
Based on the lease and mortgage loan yields and the fixed interest rate
on the acquisition loan, the transactions are expected to be immediately
accretive to MPT’s Normalized FFO per share by $0.04 in the first year
after closing. In addition, MPT’s interest in the equity of the operator
is expected to result in $0.02 or more per share based on Capella’s
recent operating results.
Also as previously announced, during the second quarter MPT executed a
new $250 million master lease and development commitment with Adeptus
for free-standing emergency facilities and executed sale and leaseback
agreements for 32 MEDIAN properties, of which 30 have been acquired as
of July 31. The 30 properties had an aggregate purchase price of €627
million; one facility with an approximate purchase price of €20 million
is expected to close during the third quarter, leaving four facilities
with an aggregate purchase price of €58 million expected to close during
the remainder of 2015.
During the second quarter the Company established an arrangement with
AXA Real Estate, a leading real estate portfolio and asset manager in
Europe and globally, to pursue hospital real estate investment
opportunities in Europe. MPT and AXA Real Estate have entered into two
joint ventures, the first for the purchase of a general acute care
hospital under development in Spain, and the second for the purchase of
several acute care hospitals and a freestanding clinic in northern
Italy. The acquisition costs of each venture will be evenly incurred by
MPT and affiliates and clients of AXA Real Estate, with MPT’s portion
expected to be approximately €112 million in the aggregate for all
properties. Both joint ventures will be managed locally by affiliates of
AXA Real Estate, and the properties will be leased under long-term
agreements.
Aldag commented, “AXA Real Estate is an experienced investor in European
real estate with strong local management resources that, when partnered
with MPT’s unique expertise in hospital real estate, creates a powerful
relationship. As we continue our growth and diversification strategy, we
are very pleased to take this first step in what has the potential to
become a growing, long-term relationship.”
Also during the second quarter, the Company executed a $20 million
agreement with Ernest to develop an inpatient rehabilitation hospital in
Toledo, Ohio, pursuant to pre-existing master lease agreements. The
Company and Ernest also acquired for aggregate consideration of $44
million a hospital campus in Lubbock, Texas, that includes a 60-bed
inpatient rehabilitation hospital to be operated by Ernest in a joint
venture with a local not for profit system, and a 37-bed long term acute
care hospital that Ernest will sublease to a third party operator.
After completion of construction and commencement of operations during
the quarter of five Adeptus facilities, MPT is collecting rental
payments on 25 facilities and expects to complete and place in service
an additional nine facilities by December 31, 2015. Pursuant to the
terms of the master lease agreements with Adeptus, MPT’s cash rents
exceed 10% of its aggregate investments.
As of June 30, 2015, the Company had total gross assets of approximately
$4.4 billion consisting of 167 properties in 28 states and in Germany
and the United Kingdom. The properties are leased to or mortgaged by 28
hospital operating companies. Including completion of pending
acquisition and development commitments, the Company projects total
gross assets of approximately $5.8 billion comprising more than 195
hospital properties when achieved.
OPERATING RESULTS AND OUTLOOK
Normalized FFO for the second quarter increased 41% to $62.9 million
compared with $44.5 million in the second quarter of 2014. Per share
Normalized FFO increased 15% to $0.30 per diluted share in the second
quarter compared with $0.26 per share in the second quarter of 2014.
Second quarter 2015 total revenues increased 30% to $99.8 million
compared with $76.6 million for the second quarter of 2014.
Net income for the second quarter of 2015 was $22.4 million (or $0.11
per diluted share), up from net loss of $(0.2) million (or $0.00 per
diluted share) in the second quarter of 2014.
Based solely on the completed and pending acquisitions, development
projects currently ongoing, which does not include the new $250 million
commitment to Adeptus, and the completion of the MEDIAN sale leaseback
transactions, per share Normalized FFO is expected to range between
approximately $1.28 and $1.32 on an annual run-rate basis. This estimate
does not include potential earnings from MPT’s equity investment in
Capella.
These estimates also do not include the effects, if any, of real estate
operating costs, litigation costs, debt refinancing costs, acquisition
costs, currency exchange rate movements, interest rate hedging
activities, write-offs of straight-line rent or other non-recurring or
unplanned transactions. These estimates will change when the Company
acquires or sells assets, market interest rates change, debt is
refinanced, new shares are issued, additional debt is incurred, other
operating expenses vary, income from investments in tenant operations
vary from expectations, or existing leases do not perform in accordance
with their terms.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Tuesday,
August 4, 2015, at 11:00 a.m. Eastern Time to present the Company’s
financial and operating results for the quarter ended June 30, 2015. The
dial-in numbers for the conference call are 800-510-9691 (U.S.) and
617-614-3453 (international); both numbers require passcode 61786001.
The conference call will also be available via webcast in the Investor
Relations’ section of the Company’s website, www.medicalpropertiestrust.com.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment
trust formed to capitalize on the changing trends in healthcare delivery
by acquiring and developing net-leased healthcare facilities. MPT’s
financing model allows hospitals and other healthcare facilities to
unlock the value of their underlying real estate in order to fund
facility improvements, technology upgrades, staff additions and new
construction. Facilities include acute care hospitals, inpatient
rehabilitation hospitals, long-term acute care hospitals, and other
medical and surgical facilities. For more information, please visit the
Company’s website at www.medicalpropertiestrust.com.
The statements in this press release that are forward looking are
based on current expectations and actual results or future events may
differ materially. Words such as "expects," "believes," "anticipates,"
"intends," "will," "should” and variations of such words and similar
expressions are intended to identify such forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results of the
Company or future events to differ materially from those expressed in or
underlying such forward-looking statements, including without
limitation: the satisfaction of all conditions to, and the timely
closing (if at all) of the Capella transaction; the Company’s financing
of the transactions described herein; the satisfaction of all conditions
to, and the timely closing (if at all) of the MEDIAN sale-leaseback
transactions; Normalized FFO per share; expected payout ratio, the
amount of acquisitions of healthcare real estate, if any; capital
markets conditions, the repayment of debt arrangements; statements
concerning the additional income to the Company as a result of ownership
interests in certain hospital operations and the timing of such income;
the payment of future dividends, if any; completion of additional debt
arrangement, and additional investments; national and international
economic, business, real estate and other market conditions; the
competitive environment in which the Company operates; the execution of
the Company's business plan; financing risks; the Company's ability to
maintain its status as a REIT for federal income tax purposes;
acquisition and development risks; potential environmental and other
liabilities; and other factors affecting the real estate industry
generally or healthcare real estate in particular. For further
discussion of the factors that could affect outcomes, please refer to
the "Risk factors" section of the Company's Annual Report on Form 10-K
for the year ended December 31, 2014, and as updated by the Company’s
subsequently filed Quarterly Reports on Form 10-Q and other SEC filings.
Except as otherwise required by the federal securities laws, the Company
undertakes no obligation to update the information in this press release.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in thousands, except for per share data)
|
|
June 30, 2015
|
|
December 31, 2014
|
|
Assets
|
|
(Unaudited)
|
|
|
|
|
|
Real estate assets
|
|
|
|
|
|
|
|
|
|
Land, buildings and improvements, and intangible lease assets
|
|
$
|
2,663,249
|
|
|
$
|
2,149,612
|
|
|
Construction in progress and other
|
|
|
56,762
|
|
|
|
23,163
|
|
|
Net investment in direct financing leases
|
|
|
455,020
|
|
|
|
439,516
|
|
|
Mortgage loans
|
|
|
437,587
|
|
|
|
397,594
|
|
|
Gross investment in real estate assets
|
|
|
3,612,618
|
|
|
|
3,009,885
|
|
|
Accumulated depreciation and amortization
|
|
|
(231,909
|
)
|
|
|
(202,627
|
)
|
|
Net investment in real estate assets
|
|
|
3,380,709
|
|
|
|
2,807,258
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
45,904
|
|
|
|
144,541
|
|
|
Interest and rent receivables
|
|
|
56,792
|
|
|
|
41,137
|
|
|
Straight-line rent receivables
|
|
|
68,927
|
|
|
|
59,128
|
|
|
Other assets
|
|
|
673,793
|
|
|
|
695,272
|
|
|
Total Assets
|
|
$
|
4,226,125
|
|
|
$
|
3,747,336
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
Debt, net
|
|
$
|
2,262,861
|
|
|
$
|
2,201,654
|
|
|
Accounts payable and accrued expenses
|
|
|
130,505
|
|
|
|
112,623
|
|
|
Deferred revenue
|
|
|
27,541
|
|
|
|
27,207
|
|
|
Lease deposits and other obligations to tenants
|
|
|
9,341
|
|
|
|
23,805
|
|
|
Total Liabilities
|
|
|
2,430,248
|
|
|
|
2,365,289
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value. Authorized 10,000 shares; no
shares outstanding
|
|
|
-
|
|
|
|
-
|
|
|
Common stock, $0.001 par value. Authorized 250,000 shares; issued
and outstanding - 207,804 shares at June 30, 2015, and 172,743
shares at December 31, 2014
|
|
|
208
|
|
|
|
172
|
|
|
Additional paid in capital
|
|
|
2,250,894
|
|
|
|
1,765,381
|
|
|
Distributions in excess of net income
|
|
|
(395,078
|
)
|
|
|
(361,330
|
)
|
|
Accumulated other comprehensive loss
|
|
|
(59,885
|
)
|
|
|
(21,914
|
)
|
|
Treasury shares, at cost
|
|
|
(262
|
)
|
|
|
(262
|
)
|
|
Total Equity
|
|
|
1,795,877
|
|
|
|
1,382,047
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities and Equity
|
|
$
|
4,226,125
|
|
|
$
|
3,747,336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Income
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Six Months Ended
|
|
|
|
June 30, 2015
|
|
June 30, 2014
|
|
June 30, 2015
|
|
June 30, 2014
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rent billed
|
|
$
|
53,893
|
|
|
$
|
45,928
|
|
|
$
|
106,994
|
|
|
$
|
88,889
|
|
|
Straight-line rent
|
|
|
5,252
|
|
|
|
3,178
|
|
|
|
9,980
|
|
|
|
5,366
|
|
|
Income from direct financing leases
|
|
|
12,808
|
|
|
|
12,263
|
|
|
|
25,363
|
|
|
|
24,479
|
|
|
Interest and fee income
|
|
|
27,848
|
|
|
|
15,191
|
|
|
|
53,425
|
|
|
|
30,915
|
|
|
Total revenues
|
|
|
99,801
|
|
|
|
76,560
|
|
|
|
195,762
|
|
|
|
149,649
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate depreciation and amortization
|
|
|
14,956
|
|
|
|
12,442
|
|
|
|
29,712
|
|
|
|
26,131
|
|
|
Impairment charges
|
|
|
-
|
|
|
|
29,631
|
|
|
|
-
|
|
|
|
50,128
|
|
|
Property-related
|
|
|
530
|
|
|
|
(38
|
)
|
|
|
881
|
|
|
|
700
|
|
|
Acquisition expenses
|
|
|
25,809
|
|
|
|
2,535
|
|
|
|
32,048
|
|
|
|
3,047
|
|
|
General and administrative
|
|
|
10,642
|
|
|
|
8,206
|
|
|
|
21,547
|
|
|
|
17,165
|
|
|
Total operating expenses
|
|
|
51,937
|
|
|
|
52,776
|
|
|
|
84,188
|
|
|
|
97,171
|
|
|
Operating income
|
|
|
47,864
|
|
|
|
23,784
|
|
|
|
111,574
|
|
|
|
52,478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense)
|
|
|
(24,812
|
)
|
|
|
(23,947
|
)
|
|
|
(52,171
|
)
|
|
|
(45,389
|
)
|
|
Income tax (expense) benefit
|
|
|
(563
|
)
|
|
|
(40
|
)
|
|
|
(938
|
)
|
|
|
16
|
|
|
Income (loss) from continuing operations
|
|
|
22,489
|
|
|
|
(203
|
)
|
|
|
58,465
|
|
|
|
7,105
|
|
|
Income (loss) from discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
Net income (loss)
|
|
|
22,489
|
|
|
|
(203
|
)
|
|
|
58,465
|
|
|
|
7,103
|
|
|
Net income (loss) attributable to non-controlling interests
|
|
|
(82
|
)
|
|
|
-
|
|
|
|
(161
|
)
|
|
|
(65
|
)
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
22,407
|
|
|
$
|
(203
|
)
|
|
$
|
58,304
|
|
|
$
|
7,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - basic and diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$
|
0.11
|
|
|
$
|
-
|
|
|
$
|
0.28
|
|
|
$
|
0.04
|
|
|
Income (loss) from discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
0.11
|
|
|
$
|
-
|
|
|
$
|
0.28
|
|
|
$
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.22
|
|
|
$
|
0.21
|
|
|
$
|
0.44
|
|
|
$
|
0.42
|
|
|
|
|
|
|
|
|
|
.
|
|
|
|
|
|
|
|
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
208,071
|
|
|
|
171,718
|
|
|
|
205,515
|
|
|
|
167,846
|
|
|
Weighted average shares outstanding - diluted
|
|
|
208,640
|
|
|
|
172,369
|
|
|
|
206,127
|
|
|
|
168,459
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
Reconciliation of Net Income to Funds From Operations
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Six Months Ended
|
|
|
|
June 30, 2015
|
|
June 30, 2014
|
|
June 30, 2015
|
|
June 30, 2014
|
|
FFO information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
22,407
|
|
|
$
|
(203
|
)
|
|
$
|
58,304
|
|
|
$
|
7,038
|
|
|
Participating securities' share in earnings
|
|
|
(250
|
)
|
|
|
(195
|
)
|
|
|
(516
|
)
|
|
|
(404
|
)
|
|
Net income (loss), less participating securities' share in earnings
|
|
$
|
22,157
|
|
|
$
|
(398
|
)
|
|
$
|
57,788
|
|
|
$
|
6,634
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
14,956
|
|
|
|
12,442
|
|
|
|
29,712
|
|
|
|
26,131
|
|
|
Real estate impairment charges
|
|
|
-
|
|
|
|
5,974
|
|
|
|
-
|
|
|
|
5,974
|
|
|
Funds from operations
|
|
$
|
37,113
|
|
|
$
|
18,018
|
|
|
$
|
87,500
|
|
|
$
|
38,739
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
950
|
|
|
Unutilized financing fees / debt refinancing costs
|
|
|
-
|
|
|
|
291
|
|
|
|
238
|
|
|
|
291
|
|
|
Loan and other impairment charges
|
|
|
-
|
|
|
|
23,657
|
|
|
|
-
|
|
|
|
44,154
|
|
|
Acquisition costs
|
|
|
25,809
|
|
|
|
2,535
|
|
|
|
32,048
|
|
|
|
3,047
|
|
|
Normalized funds from operations
|
|
$
|
62,922
|
|
|
$
|
44,501
|
|
|
$
|
119,786
|
|
|
$
|
87,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
2,598
|
|
|
|
2,075
|
|
|
|
5,200
|
|
|
|
4,119
|
|
|
Debt costs amortization
|
|
|
1,394
|
|
|
|
1,144
|
|
|
|
2,771
|
|
|
|
2,193
|
|
|
Additional rent received in advance (A)
|
|
|
(300
|
)
|
|
|
(300
|
)
|
|
|
(600
|
)
|
|
|
(600
|
)
|
|
Straight-line rent revenue and other
|
|
|
(6,928
|
)
|
|
|
(4,830
|
)
|
|
|
(13,260
|
)
|
|
|
(9,533
|
)
|
|
Adjusted funds from operations
|
|
$
|
59,686
|
|
|
$
|
42,590
|
|
|
$
|
113,897
|
|
|
$
|
83,360
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per diluted share data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss), less participating securities' share in earnings
|
|
$
|
0.11
|
|
|
$
|
-
|
|
|
$
|
0.28
|
|
|
$
|
0.04
|
|
|
Depreciation and amortization
|
|
|
0.07
|
|
|
|
0.07
|
|
|
|
0.14
|
|
|
|
0.16
|
|
|
Real estate impairment charges
|
|
|
-
|
|
|
|
0.03
|
|
|
|
-
|
|
|
|
0.03
|
|
|
Funds from operations
|
|
$
|
0.18
|
|
|
$
|
0.10
|
|
|
$
|
0.42
|
|
|
$
|
0.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.01
|
|
|
Unutilized financing fees / debt refinancing costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Loan and other impairment charges
|
|
|
-
|
|
|
|
0.14
|
|
|
|
-
|
|
|
|
0.26
|
|
|
Acquisition costs
|
|
|
0.12
|
|
|
|
0.02
|
|
|
|
0.16
|
|
|
|
0.02
|
|
|
Normalized funds from operations
|
|
$
|
0.30
|
|
|
$
|
0.26
|
|
|
$
|
0.58
|
|
|
$
|
0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
0.03
|
|
|
|
0.02
|
|
|
Debt costs amortization
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
0.01
|
|
|
Additional rent received in advance (A)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Straight-line rent revenue and other
|
|
|
(0.03
|
)
|
|
|
(0.03
|
)
|
|
|
(0.07
|
)
|
|
|
(0.06
|
)
|
|
Adjusted funds from operations
|
|
$
|
0.29
|
|
|
$
|
0.25
|
|
|
$
|
0.55
|
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Represents additional rent received from one tenant in
advance of when we can recognize as revenue for accounting
purposes.
|
|
This additional rent is being recorded to revenue on a straight-line
basis over the lease life.
|
|
|
Investors and analysts following the real estate industry utilize funds
from operations, or FFO, as a supplemental performance measure. FFO,
reflecting the assumption that real estate asset values rise or fall
with market conditions, principally adjusts for the effects of GAAP
depreciation and amortization of real estate assets, which assumes that
the value of real estate diminishes predictably over time. We compute
FFO in accordance with the definition provided by the National
Association of Real Estate Investment Trusts, or NAREIT, which
represents net income (loss) (computed in accordance with GAAP),
excluding gains (losses) on sales of real estate and impairment charges
on real estate assets, plus real estate depreciation and amortization
and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition,
we also disclose normalized FFO,which adjusts FFO for items that relate
to unanticipated or non-core events or activities or accounting changes
that, if not noted, would make comparison to prior period results and
market expectations less meaningful to investors and analysts. We
believe that the use of FFO, combined with the required GAAP
presentations, improves the understanding of our operating results among
investors and the use of normalized FFO makes comparisons of our
operating results with prior periods and other companies more
meaningful. While FFO and normalized FFO are relevant and widely used
supplemental measures of operating and financial performance of REITs,
they should not be viewed as a substitute measure of our operating
performance since the measures do not reflect either depreciation and
amortization costs or the level of capital expenditures and leasing
costs necessary to maintain the operating performance of our properties,
which can be significant economic costs that could materially impact our
results of operations. FFO and normalized FFO should not be considered
an alternative to net income (loss) (computed in accordance with GAAP)
as indicators of our financial performance or to cash flow from
operating activities (computed in accordance with GAAP) as an indicator
of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting
from or adding to normalized FFO (i) unbilled rent revenue, (ii)
non-cash share-based compensation expense, and (iii) amortization of
deferred financing costs. AFFO is an operating measurement that we use
to analyze our results of operations based on the receipt, rather than
the accrual, of our rental revenue and on certain other adjustments. We
believe that this is an important measurement because our leases
generally have significant contractual escalations of base rents and
therefore result in recognition of rental income that is not collected
until future periods, and costs that are deferred or are non-cash
charges. Our calculation of AFFO may not be comparable to AFFO or
similarly titled measures reported by other REITs. AFFO should not be
considered as an alternative to net income (calculated pursuant to GAAP)
as an indicator of our results of operations or to cash flow from
operating activities (calculated pursuant to GAAP) as an indicator of
our liquidity.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150804006012/en/
Source: Medical Properties Trust, Inc.
Medical Properties Trust, Inc.
Tim Berryman, 205-969-3755
Director
– Investor Relations
tberryman@medicalpropertiestrust.com